Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Physicians, cardiologists weigh future of obesity management
• Is the change in health care being driven solely on a financial basis? Jeffrey E. Epstein, MD; Frank W. Smart, MD
• Angiotensin receptor blocker use may not be linked to cancer
• Antihypertensive therapies lowered risk for HF in patients with hypertension
• APEX-AMI: Age strongest predictor of 90-day mortality
• Combined diet, exercise more beneficial in older obese adults than either intervention alone
• Conflicting recommendations exist among imaging guidelines for detecting asymptomatic CAD
• CV outcomes highly attributed to hypertension among Framingham participants with diabetes
• Early-, late-onset diabetes increased mortality, major CHD event risk in older men
• EISNER: CAC scanning associated with improved risk factors vs. no scanning
• Exclusion of older patients prevalent among trials testing HF treatments
• FDA issues warning on dabigatran handling, storage
• Global launch of 3-D tricuspid ring announced
• Modifiable risk factors may account for half the cases of AF
• Neoatherosclerosis observed more frequently with drug-eluting stents
• One-third of patients treated with TAVI device required permanent pacemaker at 30 days
• PRECOMBAT: Sirolimus-eluting stent non-inferior to CABG in patients with unprotected left main CAD
• PROTECT: Dalteparin not superior to unfractionated heparin in critically ill patients
• Researchers examine CV risks related to chronic kidney disease treatments
• Screening tool improved appropriate referrals for ICD implant
• Serum alpha-carotene inversely associated with death from CVD, all-causes
• Study findings elucidate common form of pulmonary hypertension
• SYNTAX: Angina slightly improved in CABG vs. PCI patients
• Transient ischemic attack doubled risk for MI
• Troponin I assay improved detection of MI in patients with suspected ACS
• Wrist circumference in obese children may predict CVD
• FDA approves new family of shock-reducing ICDs and CRT-Ds
• Conflicts of interest prevalent among clinical practice guideline producers
• Dementia documented in one of five patients after first-ever stroke
• Mercury exposure not linked with CVD in US adults
• Mortality benefit of primary PCI vs. thrombolytic strategies found reduced
• No difference after ablation found in AF patients treated with antiarrhythmic drugs
• Study: Prevalence of resistant hypertension found in daily practice
• Paul L. Douglass, MD, helping to redefine health care for women, minorities
• Combination therapy plus LVAD not validated in multicenter trial
• EVEREST II: Safety, efficacy remain stable at 2 years
• MAGELLAN: Rivaroxaban efficacy comparable to enoxaparin in acutely ill
• PARTNER A: Mortality comparable between TAVR and AVR procedures
• PARTNER B: Data reveal TAVR cost-competitive in elderly, inoperable patients
• RAPS: Better graft closure reported in radial artery vs. saphenous vein grafts
• RESOLUTE US: TLF lowered at 1 year with Resolute vs. Endeavor stent
• STICH: CABG plus medical therapy yields marginal benefit in patients with HF, CAD
• Study: Myocardial viability imaging, CABG effectiveness not linked
• Heart failure and anticoagulation: The verdict is still out Corrine Young, PharmD, BCPS